Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

MLA

Ji, Tongting, et al. “Targeting RBM39 through Indisulam Induced Mis-Splicing of MRNA to Exert Anti-Cancer Effects in T-Cell Acute Lymphoblastic Leukemia.” Journal of Experimental & Clinical Cancer Research : CR, vol. 43, no. 1, July 2024, p. 205. EBSCOhost, https://doi.org/10.1186/s13046-024-03130-8.

APA

Ji, T., Yang, Y., Yu, J., Yin, H., Chu, X., Yang, P., Xu, L., Wang, X., Hu, S., Li, Y., Wu, X., Liu, W., Zhou, B., Wang, W., Zhang, S., Cheng, W., Chen, Y., Shi, L., Li, Z., … Lu, J. (2024). Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia. Journal of Experimental & Clinical Cancer Research : CR, 43(1), 205. https://doi.org/10.1186/s13046-024-03130-8

Chicago

Ji, Tongting, Yang Yang, Juanjuan Yu, Hongli Yin, Xinran Chu, Pengju Yang, Ling Xu, et al. 2024. “Targeting RBM39 through Indisulam Induced Mis-Splicing of MRNA to Exert Anti-Cancer Effects in T-Cell Acute Lymphoblastic Leukemia.” Journal of Experimental & Clinical Cancer Research : CR 43 (1): 205. doi:10.1186/s13046-024-03130-8.